MetLife Investment Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Buy |
122,503
+47,717
| +64% | +$47K | ﹤0.01% | 2450 |
|
|
2025
Q1 | $108K | Sell |
74,786
-42,946
| -36% | -$61.8K | ﹤0.01% | 2491 |
|
|
2024
Q4 | $259K | Buy |
117,732
+46,682
| +66% | +$103K | ﹤0.01% | 2164 |
|
|
2024
Q3 | $117K | Buy |
71,050
+22,734
| +47% | +$37.5K | ﹤0.01% | 2565 |
|
|
2024
Q2 | $107K | Buy |
+48,316
| New | +$107K | ﹤0.01% | 2571 |
|
|
2023
Q2 | – | Sell |
-13,642
| Closed | -$21.7K | – | 2954 |
|
|
2023
Q1 | $21.7K | Sell |
13,642
-21,044
| -61% | -$33.5K | ﹤0.01% | 2771 |
|
|
2022
Q4 | $216K | Hold |
34,686
| – | – | ﹤0.01% | 2202 |
|
|
2022
Q3 | $232K | Buy |
34,686
+4,925
| +17% | +$33K | ﹤0.01% | 2197 |
|
|
2022
Q2 | $189K | Sell |
29,761
-5,349
| -15% | -$34K | ﹤0.01% | 2362 |
|
|
2022
Q1 | $163K | Buy |
+35,110
| New | +$163K | ﹤0.01% | 2474 |
|
|
2021
Q4 | – | Sell |
-5,894
| Closed | -$71K | – | 2519 |
|
|
2021
Q3 | $71K | Sell |
5,894
-6,792
| -54% | -$81.8K | ﹤0.01% | 2512 |
|
|
2021
Q2 | $268K | Hold |
12,686
| – | – | ﹤0.01% | 1965 |
|
|
2021
Q1 | $356K | Hold |
12,686
| – | – | ﹤0.01% | 1716 |
|
|
2020
Q4 | $330K | Hold |
12,686
| – | – | ﹤0.01% | 1707 |
|
|
2020
Q3 | $472K | Hold |
12,686
| – | – | 0.01% | 1392 |
|
|
2020
Q2 | $651K | Buy |
12,686
+1,785
| +16% | +$91.6K | 0.01% | 1239 |
|
|
2020
Q1 | $344K | Hold |
10,901
| – | – | ﹤0.01% | 1418 |
|
|
2019
Q4 | $650K | Hold |
10,901
| – | – | 0.01% | 1311 |
|
|
2019
Q3 | $400K | Hold |
10,901
| – | – | ﹤0.01% | 1546 |
|
|
2019
Q2 | $507K | Hold |
10,901
| – | – | 0.01% | 1472 |
|
|
2019
Q1 | $438K | Hold |
10,901
| – | – | ﹤0.01% | 1537 |
|
|
2018
Q4 | $501K | Hold |
10,901
| – | – | 0.01% | 1369 |
|
|
2018
Q3 | $484K | Hold |
10,901
| – | – | 0.01% | 1571 |
|
|
2018
Q2 | $427K | Buy |
10,901
+3,363
| +45% | +$132K | 0.01% | 1499 |
|
|
2018
Q1 | $545K | Hold |
7,538
| – | – | 0.01% | 1323 |
|
|
2017
Q4 | $496K | Buy |
+7,538
| New | +$496K | 0.01% | 1392 |
|